Bictegravir is a potent HIV-1 integrase inhibitor primarily used to treat type 1 AIDS without a history of antiretroviral therapy.
(HIV-1) adult patients, it can also be used as an alternative drug for patients with no history of treatment failure and drug resistance and HIV-1 RNA less than 50copies/ml.
This report contains market size and forecasts of Bictegravir in global, including the following market information:
Global Bictegravir Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bictegravir Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Bictegravir companies in 2021 (%)
The global Bictegravir market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
97% - 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bictegravir include Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience and Jiangsu Coben Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bictegravir manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bictegravir Market, by Purity, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Bictegravir Market Segment Percentages, by Purity, 2021 (%)
97% - 99%
Above 99%
Global Bictegravir Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Bictegravir Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Labs
Global Bictegravir Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Bictegravir Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bictegravir revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bictegravir revenues share in global market, 2021 (%)
Key companies Bictegravir sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Bictegravir sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Cipla
Laurus Labs
Hetero Drugs Limited
Selleck Chemicals
Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical
Changzhou Pharmaceutical Factory
Shanghai Topscience
Jiangsu Coben Pharmaceutical
ShenZhen HwaGen Pharmaceutical
Shanghai Haoyuan Chemexpress
Shanghai Systeam Biochem